Found 193 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is V  [Clear All Filters]
2026
Honey MIJ, Hok-A-Hin YS, Thijssen EH, Cousins KAQ, van der Weijden B, Veld LIn 't, Stoops E, de Boer SCM, Duits FH, de Houwer JFH et al..  2026.  An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration.. Nat Med.
Honey MIJ, Hok-A-Hin YS, Thijssen EH, Cousins KAQ, van der Weijden B, Veld LIn 't, Stoops E, de Boer SCM, Duits FH, de Houwer JFH et al..  2026.  An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration.. Nat Med.
Honey MIJ, Hok-A-Hin YS, Thijssen EH, Cousins KAQ, van der Weijden B, Veld LIn 't, Stoops E, de Boer SCM, Duits FH, de Houwer JFH et al..  2026.  An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration.. Nat Med.
Honey MIJ, Hok-A-Hin YS, Thijssen EH, Cousins KAQ, van der Weijden B, Veld LIn 't, Stoops E, de Boer SCM, Duits FH, de Houwer JFH et al..  2026.  An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration.. Nat Med.
Honey MIJ, Hok-A-Hin YS, Thijssen EH, Cousins KAQ, van der Weijden B, Veld LIn 't, Stoops E, de Boer SCM, Duits FH, de Houwer JFH et al..  2026.  An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration.. Nat Med.
DeBlois J, Einstein E, Victor JD.  2026.  Walks with jumps: a neurobiologically motivated class of paths in the hyperbolic plane.. J Math Biol. 92(3):34.
2025
Larrea D, Tamucci KA, Kabra K, Velasco KR, Yun TD, Pera M, Montesinos J, Agrawal RR, Paradas C, Smerdon JW et al..  2025.  Altered mitochondria-associated ER membrane (MAM) function shifts mitochondrial metabolism in amyotrophic lateral sclerosis (ALS).. Nat Commun. 16(1):379.
Martinez-Meza S, Premeaux TA, Cirigliano SM, Friday CM, Michael S, Mediouni S, Valente ST, Ndhlovu LC, Fine HA, O'Brien RLFurler et al..  2025.  Antiretroviral drug therapy does not reduce neuroinflammation in an HIV-1 infection brain organoid model.. J Neuroinflammation. 22(1):66.
Singh J, Chehayeb RJaber, Im Y, Yi I, Zarif TEl, Guajardo AFerrigno, VanOudenhove J, Halene S, Jha A, Kwan JM.  2025.  Clonal Hematopoiesis Risk Score (CHRS) Evaluation as a Prognostic Marker for Death in Cardio-Oncology Cohort.. JACC Adv. 4(12 Pt 2):102290.
Bellat V, Glaser A, Gong H, Gill A, Lee YJae, Cifani P, Stokol T, Vahdat L, Law B.  2025.  Customized Nanofibers with Lung-Targeting and -Retention Properties for Treating Isolated Triple-Negative Breast Cancer Pulmonary Metastases.. ACS Nano. 19(33):29994-30009.
Lu Y, Juodelyte D, Victor JD, Cheplygina V.  2025.  Exploring connections of spectral analysis and transfer learning in medical imaging.. Proc SPIE Int Soc Opt Eng. 13406
Gannarapu MReddy, Nagiri RKumar, Desagoni M, Velma GReddy.  2025.  FDA-Approved Fluorine-Containing Molecules in 2024: Significance, Synthesis, and Therapeutic Applications.. Curr Top Med Chem.
Milicevic KD, Ivanova VO, Brazil TN, Varillas CA, Zhu YMD, Andjus PR, Antic SD.  2025.  The Impact of Optical Undersampling on the Ca2+ Signal Resolution in Ca2+ Imaging of Spontaneous Neuronal Activity.. J Integr Neurosci. 24(1):26242.
Gattuso HC, van Hassel KA, Freed JD, Nuñez KM, de la Rea B, May CE, Ermentrout B, Victor JD, Nagel KI.  2025.  Inhibitory control explains locomotor statistics in walking Drosophila.. Proc Natl Acad Sci U S A. 122(16):e2407626122.
Gattuso HC, van Hassel KA, Freed JD, Nuñez KM, de la Rea B, May CE, Ermentrout B, Victor JD, Nagel KI.  2025.  Inhibitory control explains locomotor statistics in walking Drosophila.. Proc Natl Acad Sci U S A. 122(16):e2407626122.
Zhou H, Balint D, Shi Q, Vartanian T, Kriegel MA, Brito I.  2025.  Lupus and inflammatory bowel disease share a common set of microbiome features distinct from other autoimmune disorders.. Ann Rheum Dis. 84(1):93-105.
Riganello F, Cortese MD, Vatrano M, Lucca LF, Pugliese ME, Ursino M, Leto E, Cerasa A, Schiff N, Soddu A.  2025.  New insights and predictability from in vivo recordings of paroxysmal sympathetic hyperactivity in disorders of consciousness.. Clin Auton Res.
Lee J, Kang R, Park S, Saliu IO, Son M, Voorhees JR, Dimitry JM, Quillin EI, Woodie LN, Lananna BV et al..  2025.  REV-ERBα regulates brain NAD+ levels and tauopathy via an NFIL3-CD38 axis.. Nat Aging.
Foord C, Prjibelski AD, Hu W, Michielsen L, Vandelli A, Narykov O, Evans B, Hsu J, Belchikov N, Jarroux J et al..  2025.  A spatial long-read approach at near-single-cell resolution reveals developmental regulation of splicing and polyadenylation sites in distinct cortical layers and cell types.. Nat Commun. 16(1):8093.
Blackmon TJ, MacMahon JA, Bernardino PN, Hogans RE, Cheng M-Y, Vu J, Lee RDiana, Saito NH, Grodzki ACristina, Bruun DA et al..  2025.  Spatiotemporal perturbations of the plasminogen activation system in a rat model of acute organophosphate intoxication.. Acta Neuropathol Commun. 13(1):62.
Vargas-Ortiz J, Lin L, Martinez VK, Liu R-J, Babij R, Duan ZRan S, Wacks S, Sun L, Wang A, Khan S et al..  2025.  Translaminar synchronous neuronal activity is required for columnar synaptic strengthening in the mouse neocortex.. Nat Commun. 16(1):1296.
Rucci M, Ahissar E, Burr DC, Kagan I, Poletti M, Victor JD.  2025.  The visual system does not operate like a camera.. J Vis. 25(3):2.
2024
Kloske CM, Belloy ME, Blue EE, Bowman GR, Carrillo MC, Chen X, Chiba-Falek O, Davis AA, Di Paolo G, Garretti F et al..  2024.  Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference.. Alzheimers Dement.
Bravo CParra, Krukowski K, Barker S, Wang C, Li Y, Fan L, Vázquez-Rosa E, Shin M-K, Wong MYing, McCullough LD et al..  2024.  Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury.. Mol Neurodegener. 19(1):51.
Sanz LRD, Lejeune N, Szymkowicz E, Bonin EAC, Panda R, Sala A, Thibaut A, Huerta-Gutierrez R, Dardenne N, Dikenstein D et al..  2024.  Apomorphine for prolonged disorders of consciousness: a multimodal open-label study.. EClinicalMedicine. 78:102925.